PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment
Marta Pérez-González, Maite Mendioroz, Sara Badesso, Diego Sucunza, Miren Roldan, Maria Espelosín, Susana Ursua, Rafael Luján, Mar Cuadrado-Tejedor, Ana Garcia-Osta
Clinical studies revealed that some aged-individuals accumulate a significant number of histopathological Alzheimer´s disease (AD) lesions in their brain, yet without developing any signs of dementia. Animal models of AD represent suitable tools to identify genes that might promote cognitive resilience and hence, this study first set out to identify cognitively resilient individuals in the aged-Tg2576 mouse model. A transcriptomic analysis of these mice identified PLA2G4E as a gene that might confer resistance to dementia. Indeed, a significant decrease in PLA2G4E is evident in the brain of late-stage AD patients, whereas no such changes are observed in early stage patients with AD neuropathological lesions but no signs of dementia.
We demonstrated that adeno-associated viral vector-mediated overexpression of PLA2G4E in hippocampal neurons completely restored cognitive deficits in elderly APP/PS1 mice, without affecting the amyloid or tau pathology. These PLA2G4E overexpressing APP/PS1 mice developed significantly more dendritic spines than sham-injected mice, coinciding with the cognitive improvement observed. Hence, these results support the idea that a loss of PLA2G4E might play a key role in the onset of dementia in AD, highlighting the potential of PLA2G4E overexpression as a novel therapeutic strategy to manage AD and other disorders that course with memory deficits.
CITA DEL ARTÍCULO Prog Neurobiol. 2020 Aug;191:101818. doi: 10.1016/j.pneurobio.2020.101818. Epub 2020 May 5.